Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties Post author:Sam Post published:February 1, 2018 Post category:BioPharma AstraZeneca did not immediately respond to a request for comment. Source: BioSpace You Might Also Like ObsEva Fertility Drug Shows Some Promise in Late-Stage Trial February 25, 2018 GT Biopharma Promotes COO to Top Post, Effective Immediately February 14, 2018 How Gilead Just Lost $9 Billion in Market Value This Week February 8, 2017
